GlassScriptPhysician profile
David C Cummings
NPI 1881951804
$12,335.44
in general payments reported to CMS, 2019-2025
8 companies · $11K in 2025
The $11K reported for 2025 was more than what 95% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $20.99 · 2021: $126 · 2022: $151 · 2023: $744 · 2025: $11K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $8,000 · Travel and Lodging: $3,585 · Food and Beverage: $453.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $8,000.00 |
| Travel and Lodging | $3,585.05 |
| Food and Beverage | $452.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $11,983.59 | 2023-2025 | Da Vinci Surgical System |
| Integra Lifesciences Corporation | $121.17 | 2022 | |
| Abbott Laboratories | $67.28 | 2021 | |
| Smith+Nephew, INC. | $55.19 | 2021-2022 | |
| Davol INC. | $51.49 | 2019-2025 | Phasix Mesh |
| Ethicon US, LLC | $20.96 | 2025 | Enseal, Echelon; Endopath, Echelon Circular |
| Kci USA, INC. | $19.93 | 2023 | Prevena, V.A.C.Ulta |
| Medtronic, INC. | $15.83 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Cummings listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.